biotech turnaround

1 articles
The Motley FoolThe Motley Fool··Adria Cimino

Coatue Management Exits CoreWeave While Establishing Moderna Position

Coatue Management exited CoreWeave with 80% gains, reallocating capital toward a new Moderna position ahead of the biotech stock's 50% rally.
CRWVTSMMRNAportfolio rebalancing13F filings